HORMAD1 and cancer: It is postulated that this is mediated by HORMAD1 promoting efficient re‐sectioning of DSBs, making the repair of therapeutic‐induced damage more effective in cancer cells, a process that could potentially give these cells a greater evolutionary capacity.